Translational research in relation to cancer is a focus of our research. The strategic CREATE Health research center, coordinated by the department, is therefore a focal point of our research. This vision of this strategic centre is to use an integrative approach to develop novel diagnostics and therapeutics in relation to cancer. We do this mainly by identifying markers and molecular signatures that differentiate cancer from other conditions. That way we intend to create a substantial social impact for the patient, through direct application of research for selection of an optimal, individually created, cancer treatment.
The Department is hosting two COFUND programs, CanFaster-doctoral program (2018-2022) and CanFaster-postdoctoral program (2020-2024), which are performed in collaboration between three different faculties and more than 15 principle investigators at Lund University. The programs aim to attract excellent international scientific expertise with an interest in applied medical research in oncology and entrepreneurship to Lund University, CREATE health and Medicon Village. The initiatives build on collaboration between industry, healthcare and academia to strengthen and accelerate innovations and clinical implementation in oncology. The fellows will gain an understanding of unmet needs in the clinic and learn the mind-set of entrepreneurs in addition to their work in each specific cancer-oriented project.
Strategic Centre for Translational Cancer Research
MSCA-COFOUND Ph.D. and Postdoc programme for innovative cancer research
MAD for Cancer
National Bioinformatics Infrastructure Sweden
SciLifeLab Drug Discovery and Development Platform
Adaptive Immune Receptor Repertoire Community
the European Infrastructure for Translational Medicine
Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
Lund University Cancer Centre